Npj Antimicrobials and Resistance
Overview
Npj Antimicrobials and Resistance is a scientific journal, published by Nature Portfolio since 2023 in English. The journal's country of origin is United Kingdom.
Details
Details
Abbr.
NPJ Antimicrob Resist
Publisher
Nature Portfolio
Start
2023
End
Continuing
e-ISSN
2731-8745
Country
United Kingdom
Language
English
Recent Articles
1.
Cardona S, Rahman A, Novomisky Nechcoff J
NPJ Antimicrob Resist
. 2025 Mar;
3(1):19.
PMID: 40082593
Antibiotics are essential to modern medicine, but multidrug-resistant (MDR) bacterial infections threaten their efficacy. Resistance evolution shortens antibiotic lifespans, limiting investment returns and slowing new approvals. Consequently, the WHO defines...
2.
Arnold A, McLellan S, Stokes J
NPJ Antimicrob Resist
. 2025 Mar;
3(1):18.
PMID: 40082590
Antimicrobial resistance (AMR) is an urgent public health threat. Advancements in artificial intelligence (AI) and increases in computational power have resulted in the adoption of AI for biological tasks. This...
3.
Mei M, Estrada I, Diggle S, Goldberg J
NPJ Antimicrob Resist
. 2025 Feb;
3(1):17.
PMID: 40021925
R-pyocins, bacteriocin-like proteins produced by Pseudomonas aeruginosa, present a promising alternative to phage therapy and/or adjunct to currently used antimicrobials in treating bacterial infections due to their targeted specificity, lack...
4.
Delbaje E, Pontes L, Rhodes J, Steenwyk J, Lu L, Dos Reis T, et al.
NPJ Antimicrob Resist
. 2025 Feb;
3(1):15.
PMID: 40016509
The role of the fungal mitochondria goes far beyond energy metabolism. The genomes of 318 Aspergillus fumigatus clinical and environmental isolates from different geographic origins were analyzed aiming to study...
5.
Giacobbe D, Marelli C, La Manna B, Padua D, Malva A, Guastavino S, et al.
NPJ Antimicrob Resist
. 2025 Feb;
3(1):14.
PMID: 40016394
Antibiotic prescribing requires balancing optimal treatment for patients with reducing antimicrobial resistance. There is a lack of standardization in research on using large language models (LLMs) for supporting antibiotic prescribing,...
6.
Hickson S, Ledger E, Wells T
NPJ Antimicrob Resist
. 2025 Feb;
3(1):16.
PMID: 40016340
The growing problem of multi-drug resistance (MDR) is prevalent in Gram-negative infections, and the significant decline in antibiotic development poses a critical threat to global public health. Many emerging non-antibiotic...
7.
Kupke J, Brombach J, Fang Y, Wolf S, Thrukonda L, Ghazisaeedi F, et al.
NPJ Antimicrob Resist
. 2025 Feb;
3(1):13.
PMID: 39987221
Heteroresistance (HR) in bacteria describes a subpopulational phenomenon of antibiotic resistant cells of a generally susceptible population. Here, we investigated the molecular mechanisms and phenotypic characteristics underlying HR to ceftazidime...
8.
Helliwell R, Ewin I, Williams A, Levine D, Singer A, Raman S, et al.
NPJ Antimicrob Resist
. 2025 Feb;
3(1):11.
PMID: 39984758
We assess three words commonly used to represent the environmental dimensions of antimicrobial resistance (AMR) - 'hotspot', 'reservoir' and 'pristine' - through two questions: how are these terms used in...
9.
You K, Binte Mohamed Yazid N, Chong L, Hooi L, Wang P, Zhuang I, et al.
NPJ Antimicrob Resist
. 2025 Feb;
3(1):12.
PMID: 39984645
Antimicrobial resistance (AMR) is an emerging threat to global public health. Specifically, Acinetobacter baumannii (A. baumannii), one of the main pathogens driving the rise of nosocomial infections, is a Gram-negative...
10.
Muir B, Payne J, Martin J, O Shea R, Rajesh S, Blackman L, et al.
NPJ Antimicrob Resist
. 2025 Feb;
3(1):9.
PMID: 39966608
Antimicrobial resistance (AMR) poses a growing global health threat. Nanomedicine, combined with drug repurposing, may help extend the effective lifespan of current and new antimicrobials. This review, presents an Australian...